Introduction and interpretation of U.S.FDA Inspection of Injectable Products for Visible Particulates Guidance for Industry(draft guidance)

LI Yue; DONG Wu-jun; ZHANG Yao; WANG Ya-min

doi:10.3969/j.issn.1003-3734.2023.13.005

Home>Articles>Introduction and interpretation of U.S.FDA Inspection of Injectable Products for Visible Particulates Guidance for Industry(draft guidance)

DOI: 10.3969/j.issn.1003-3734.2023.13.005

Introduction and interpretation of U.S.FDA Inspection of Injectable Products for Visible Particulates Guidance for Industry(draft guidance)

LI Yue

DONG Wu-jun

ZHANG Yao

WANG Ya-min

Keywords：injectionvisible particulatescontrol strategyrisk assessmentlife cycle management

Publication Date：2023-07-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 1309-1314 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2023,32(13)